Carlos Mella-Picel
Geriatric Medicine · Chicago, ILNPI 1770713125
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 407 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Among geriatric medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 407 payments — averaging $21.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$1K
- Lilly USA, LLC$1K
- Boehringer Ingelheim$705
- Amgen$670
- AbbVie$343
- plus $3K from 27 others
What the payments were for
- Food & beverage$8,633100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 84 | $1,779 |
| Novo Nordisk | 72 | $1,408 |
| Lilly USA, LLC | 61 | $1,008 |
| Boehringer Ingelheim | 29 | $705 |
| Amgen | 30 | $670 |
| AbbVie | 17 | $343 |
| Corcept Therapeutics | 6 | $338 |
| Pfizer | 13 | $308 |
| Bayer | 8 | $267 |
| Biohaven Pharmaceuticals, Inc. | 9 | $216 |
| Sanofi-aventis U.S. LLC | 10 | $207 |
| Novartis | 6 | $195 |
| Merck | 12 | $188 |
| GSK | 8 | $150 |
| Exact Sciences | 5 | $132 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $99 |
| Otsuka America Pharmaceutical, Inc. | 3 | $80 |
| Mylan Specialty L.p. | 3 | $71 |
| Eisai Inc. | 3 | $63 |
| Agios Pharmaceuticals, Inc. | 2 | $52 |
| Seqirus USA Inc | 2 | $44 |
| Avion Pharmaceuticals | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Arbor Pharmaceuticals, Inc. | 2 | $38 |
| VBI Vaccine (delaware) Inc. | 2 | $33 |
| Redhill Biopharma Inc. | 2 | $28 |
| Ardelyx, Inc. | 1 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Gilead | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Phadia US Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,647 in reported general payments places this provider in the 95th percentile of 147 geriatric medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 113 | $135,643 |
| OzempicSemaglutide | 44 | $54,719 |
| TrulicityDulaglutide | 39 | $51,844 |
| FarxigaDapagliflozin Propanediol | 35 | $51,405 |
| MounjaroTirzepatide | 39 | $49,761 |
| EliquisApixaban | 21 | $34,396 |
| ProliaDenosumab | 20 | $34,339 |
| JanuviaSitagliptin Phosphate | 20 | $29,908 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $14,808 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $5,757 |
| JanumetSitagliptin Phos/Metformin Hcl | 21 | $3,531 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 34 | $2,814 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $1,950 |
| Atorvastatin Calcium | 242 | $1,783 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $1,537 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $705 | $135,643113 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $1,008 | $101,60578 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,779 | $57,16246 claims |
| Novo NordiskOzempic | $1,408 | $54,71944 claims |
| PfizerEliquis | $308 | $34,39621 claims |
| AmgenProlia | $670 | $34,33920 claims |
| MerckJanuvia, Janumet | $188 | $33,43941 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 147 geriatric medicine providers in Illinois.
Other geriatric medicine in Chicago
- Adeela CheemaChicago$5K
- Snigdha KolaChicago$3K
- Annie JohnChicago$2K
- Raj ShahChicago$2K
- Abbas RizviChicago$1K
- Theresa RoweChicago$1K
- Varisha SinghChicago$709
- Gretel Ruiz JorgeChicago$643
- Martin GorbienChicago$640
- Wayne WilliamsonChicago$475
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.